![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/573 | |
A61K 31/58 | |||
C12Q 1/6883 | |||
C12Q 1/6886 |
(11) | Number of the document | 3143156 |
(13) | Kind of document | T |
(96) | European patent application number | 15723409.7 |
Date of filing the European patent application | 2015-05-07 | |
(97) | Date of publication of the European application | 2017-03-22 |
(45) | Date of publication and mention of the grant of the patent | 2020-11-04 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2015/029627 |
Date | 2015-05-07 |
(87) | Number | WO 2015/175305 |
Date | 2015-11-19 |
(30) | Number | Date | Country code |
201461991710 P | 2014-05-12 | US |
(72) |
SOKOL RICCI, Deborah, US
LI, Weimin, US
GORMLEY, Michael, US
KARKERA, Jayaprakash, US
SCHAFFER, Michael, US
|
(73) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
(54) | BIOLOGICAL MARKERS FOR IDENTIFYING PATIENTS FOR TREATMENT WITH ABIRATERONE ACETATE |
BIOLOGICAL MARKERS FOR IDENTIFYING PATIENTS FOR TREATMENT WITH ABIRATERONE ACETATE |